Mesothelioma is an incurable cancer for which effective therapies are required. Aberrant MET expression is prevalent in mesothelioma. although targeting using small molecule-based therapeutics has proven disappointing. Chimeric antigen receptors (CARs) couple the HLA-independent binding of a cell surface target to the delivery of a tailored T-cell activating signal. https://fitnessgravesyardes.shop/product-category/step-platform/
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
Internet 2 hours 53 minutes ago avkxcvn5qhaabWeb Directory Categories
Web Directory Search
New Site Listings